Showing results (451-460 of 679) with videos related to
Sort By:
Pageof 68
Oncogenesis|May 16, 2017
MicroRNA-645 is an oncogenic regulator in colon cancerS T Guo, X Y Guo, J Wang, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 6, 2024
[Analysis on personal protection in occupational population at high risk for brucellosis and influencing factor in China]Z Wang, S S Lin, X R Liu, et al.Clinical and Experimental Immunology|March 3, 2017
The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosisY F Wang, D D He, H W Liang, et al.Public Health|September 10, 2021
Mental distress and its associations with behavioral outcomes during the COVID-19 pandemic: a national survey of Chinese adultsL Ma, L W Gao, J T-F Lau, et al.Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I study of the antineovascularization drug CM101R F DeVore, C G Hellerqvist, G B Wakefield, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 18, 2026
[Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer]X X Qiao, Q M Liu, Y F Wang, et al.The Review of Scientific Instruments|August 6, 2020
Diagnostic development for parallel wave-number measurement of lower hybrid waves in EASTY F Wang, B J Ding, M H Li, et al.Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 30, 2000
Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkeyS K Paulson, J Y Zhang, S M Jessen, et al.Pageof 68